Apixaban
Oral Apixaban for the Treatment of Acute Venous Thromboembolism, AMPLIFY
Apixaban for extended treatment of Venous Thromboembolism,AMPLIFY-EXT
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients, ADOPT
Apixaban versus Warfarin in Patients with Atrial Fibrillation, ARISTOTLE/N Engl J Med
Apixaban with antiplatelet therapy after acute coronary syndrome,APPRAISE-2
Apixaban in patients with atrial fibrillation, AVERROES
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement, ADVANCE-3
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement, ADVANCE 2
Apixaban or enoxaparin for thromboprophylaxis after knee replacement, N Engl J Med
Apixaban in combination with antiplatelet therapy after ACS, APPRAISE
Dabigatran
Removal of Dabigatran by Hemodialysis Case Report, NKF
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves, RE-ALIGN
Dabigatran etexilate: A novel oral direct thrombin inhibitor, AJHP [PDF]
Dabigatran versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med
Dabigatran, Warfarin, or Placebo in VTE, N Engl J Med
Dabigatran vs. placebo in ACS on dual antiplatelet therapy, RE-DEEM
Dabigatran vs. Warfarin in the Treatment of Acute Venous Thromboembolism, RE-COVER
Heparin
Weight-based heparin protocol using antifactor Xa monitoring, AJHP
Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients, N Engl J Med
Rivaroxaban
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients, MAGELLAN
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, N Engl J Med
Rivaroxaban: An oral direct inhibitor of factor Xa, AJHP
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Hip Arthroplasty, RECORD1
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty, RECORD3
Oral Rivaroxaban for Symptomatic Venous Thromboembolism, EINSTEIN
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome, ATLAS ACS2-TIMI 51
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism, EINSTEIN-PE
Warfarin
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation, Arch Intern Med 2010;170:1433-1441
Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms, Arch Toxicol
Drug-drug interactions between warfarin and psychotropics, Pharmacotherapy
Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy, Pharmacotherapy
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study, J Am Coll Cardiol
Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic, JMCP [PDF]
Development and implementation of pharmacist-managed inpatient anticoagulation monitoring program, AJHP
Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics, AJHP
